Skip to content

Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia

Efficacy of Game-Based EMG-Biofeedback Therapy in Post-Stroke Dysphagia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05832658
Enrollment
33
Registered
2023-04-27
Start date
2023-05-07
Completion date
2023-10-14
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biofeedback, Dysphagia, Stroke, Surface Electromyography, Swallowing Disorder

Brief summary

This study aims to determine the effectiveness of game-based biofeedback application via surface electromyography in patients with post-stroke dysphagia. The same treatment interventions will be applied with and without biofeedback, and thus the contribution of adding biofeedback to the treatment will be determined.

Interventions

DEVICEWith EMG-Biofeedback

Once a day for a total of 15 sessions, the Mendelsohn maneuver will be performed for 15 minutes and the effortful swallow maneuver will be performed for 15 minutes with game-based emg-biofeedback.

BEHAVIORALWithout EMG-Biofeedback

Once a day for a total of 15 sessions, the Mendelsohn maneuver will be performed for 15 minutes and the effortful swallow maneuver will be performed for 15 minutes with only verbal feedback.

BEHAVIORALUsual Care

Patient and family education will be provided by the investigator. In addition, each patient will be evaluated and oral motor exercises and thermal tactile stimulation will be given to each patient when necessary.

Sponsors

Kocaeli University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. History of hemorrhagic or ischemic stroke longer than 3 months 2. Being over the age of eighteen 3. Level ≤ 6 on the Functional Oral Intake Scale (FOIS) 4. Post-stroke onset of swallowing complaints 5. Ability to communicate with the patient and carry out the given commands 6. Mini mental test evaluation ≥ 24 points 7. Absence of concomitant serious systemic disease (unregulated hypertension, decompensated heart failure, malignancy, infection, pacemaker, epilepsy, etc.) 8. Detection of pathology in the oropharyngeal phase of swallowing in videofluoroscopic evaluation 9. Not taking any swallowing-related treatment in the last 3 months

Exclusion criteria

1. History of neoplastic disease and/or radiotherapy to the head and neck region 2. Having additional musculoskeletal disease or non-stroke neurologic disease that may cause swallowing disorders 3. Unable to communicate or carry out commands 4. Inability to maintain head-holding balance 5. Patients with severe pathology in bolus formation or delivery of the bolus to the pharynx during the oral swallowing phase

Design outcomes

Primary

MeasureTime frameDescription
Gugging Swallowing Screen (GUSS)From baseline to the end of the treatment ( 3 week)It is used to determine the severity of dysphagia and the risk of aspiration in patients with acute stroke. It is evaluated out of 20 points. It recommends videofluoroscopy as an advanced examination for patients with a score of less than 20.
Functional Oral Intake Scale (FOIS)From baseline to the end of the treatment ( 3 week)7 point scale from 1-7. Higher number indicated increased amount and normality of oral intake.
Penetration Aspiration Scale (PAS)From baseline to the end of the treatment ( 3 week)Videofluoroscopic evaluation is performed. It is an 8-point scale. The higher the number, the greater the increase in penetration/aspiration. 1 means no penetration and no aspiration. 8 means there is aspiration and there is no patient response.
Functional Dysphagia Scale (FDS)From baseline to the end of the treatment ( 3 week)Videofluoroscopic evaluation is performed. It is a total of 100 points scale. A higher score indicates more severe dysphagia.
Dysphagia Outcome and Severity Scale (DOSS)From baseline to the end of the treatment ( 3 week)Videofluoroscopic evaluation is performed. It is a 7-point scale. A score of 6 and 7 represents normal swallowing, a score of 5 represents mild dysphagia, a score of 2 to 4 represents moderate dysphagia, and a score of 1 represents severe dysphagia.
Dysphagia Handicap Index (DHI)From baseline to the end of the treatment ( 3 week)Dysphagia Handicap Index (DHI) is a self-assessment questionnaire which consists of 25 statements to examine three aspects of dysphagia patients' quality of life (QoL): functional, physical, and emotional. The patient can get a maximum score of 100 points.A higher score indicates a more severe swallowing disorder.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026